Urogen Pharma Ltd. (URGN)

Market is closed

Sector: Pharmaceutical Preparations

Hedge Fund Popularity

Display

Display Share Price

Hedge Fund Holdings

Filing Period: Filing is Ongoing

Last updated on May 09, 2025, 4:14 pm based on SEC 13F filings Last update: May 09, 2025, 4:14 pm

No.	Hedge Fund	Shares	Value	Activity	% Port
1.	Leucadia National Ian Cumming And Joseph Steinberg	815,000	$9,013,900	-16%	0.08%
2.	Wildcat Capital Management Leonard A. Potter	495,606	$5,481,402		2.93%
3.	ARK Investment Management Catherine D. Wood	185,790	$2,054,837	+33%	0.02%

Insider Trading: Purchases See All

Insider	Price	Amount	Relationship	Remaining Holdings	Date	Form 4
Schoenberg	$13.10	160	Officer	21,997	2021-11-18	Filing
Henderson	$15.85	2,500	Officer	2,500	2021-05-17	Filing
Smith	$15.71	2,500	Officer	2,500	2021-05-17	Filing
Barrett	$18.50	10,000	Officer	229,117	2020-12-14	Filing
Barrett	$28.00	7,530	Officer	16,548	2019-11-21	Filing

Insider Trading: Sales See All

Insider	Price	Amount	Relationship	Remaining Holdings	Date	Form 4
Schoenberg	$11.14	1,896	Officer	148,540	2025-01-31	Filing
Schoenberg	$11.14	1,896	Officer	147,103	2025-01-31	Filing
Schoenberg	$11.14	759	Officer	145,666	2025-01-31	Filing
Smith	$11.14	2,767	Officer	32,514	2025-01-31	Filing
Smith	$11.14	3,354	Officer	29,781	2025-01-31	Filing

Institutional Investors' Holdings

Filing Period: Filing is Ongoing

No.	Name	Shares	Value	% Port
1.	Blackrock, Inc.	2,423,463	$26,803,500	0%
2.	Goldman Sachs Group Inc	284,334	$3,144,734	0%
3.	Rice Hall James & Associates, Llc	255,791	$2,829,048	0.17%
4.	Vanguard Group Inc	250,429	$2,769,744	0%
5.	Privium Fund Management B.v.	107,622	$1,190,299	0.31%